Brief Symptom Inventory (BSI (original) (raw)
Related papers
Brief Symptom Inventory - Test Review
D. Forms; groups to which applicable: The Brief Symptom Inventory (BSI) was derived from the Symptom Checklist-90-Revised which was the first derivative of the Hopkins Symptom Checklist . There is also an 18-item short form questionnaire. It is intended for use with adult non-patients, adult psychiatric outpatients, adult psychiatric inpatients and adolescent nonpatients of at least 13 years in age. It requires a 6 th grade reading level and the author states that the BSI can be reliably administered in a narrative mode to patients who cannot read. It is available in English or Spanish and French for Canada as well as several other languages.
Sixand Ten-Item Indexes of Psychological Distress Based on the Symptom Checist-90
Assessment, 2000
Clinicians, provider organizations, and researchers need simple and valid measures to monitor mental health treatment outcomes. This paper describes development of six-and tenitem indices of psychological distress based on the Symptom Checklist-90 (SCL-90). A review of eight factor-analytic studies identified SCL-90 items most indicative of overall distress. Convergent validity of two new indices and the previously developed SCL-10 were compared in an archival sample of PTSD patients (n = 323). One index, the SCL-6, was further validated with archival data on substance abuse patients (n = 3,014 and n = 316) and hospital staff (n = 542). The three brief scales had similar convergent validity, correlating .87 to .97 with the SCL-90 and Brief Symptom Inventory, .49 to .76 with other symptom scales, and .46 to .73 with changes in other symptom measures over time. These results indicate the concise, easily administered scales are valid indicators of psychological distress.
Patient Health Questionnaire Anxiety and Depression Scale
PsycTESTS Dataset, 2016
Objective-We examine the reliability and validity of the Patient Health Questionnaire Anxiety-Depression Scale (PHQ-ADS)-which combines the PHQ-9 and GAD-7 scales-as a composite measure of depression and anxiety. Methods-Baseline data from 896 patients enrolled in 2 primary-care based trials of chronic pain and 1 oncology-practice based trial of depression and pain were analyzed. The internal reliability, standard error of measurement (SEM), and convergent, construct, and factor structure validity, as well as sensitivity to change of the PHQ-ADS were examined. Results-The PHQ-ADS demonstrated high internal reliability (Cronbach's alpha of 0.8 to 0.9) in all 3 trials. PHQ-ADS scores can range from 0 to 48 (with higher scores indicating more severe depression/anxiety), and the estimated SEM was approximately 3 to 4 points. The PHQ-ADS showed strong convergent (most correlations 0.7-0.8 range) and construct (most correlations 0.4-0.6 range) validity when examining its association with other mental health, quality of life and disability measures. PHQ-ADS cutpoints of 10, 20, and 30 indicated mild, moderate, and severe levels of depression/anxiety, respectively. Bi-factor analysis showed sufficient unidimensionality of the PHQ-ADS score. PHQ-ADS change scores at 3 months differentiated (P < .0001) between individuals classified as worse, stable, or improved by a reference measure, providing preliminary evidence for sensitivity to change. Conclusions-The PHQ-ADS may be a reliable and valid composite measure of depression and anxiety which, if validated in other populations, could be useful as a single measure for jointly assessing two of the most common psychological conditions in clinical practice and research.
The authors conducted three studies to construct and examine the psychometric properties of a 27-item version of the Mood and Anxiety Symptom Questionnaire-90 (MASQ-90; Watson & Clark, 1991a). The Anxiety Depression Distress Inventory-27 (ADDI-27) contains three empirically derived scales: Positive Affect, Somatic Anxiety, and General Distress, which are relevant dimensions of the tripartite model of affect. Each scale is composed of nine items, and the estimate of scale reliability for each scale score was Z.80 across the three studies. Results of exploratory and confirmatory factor analyses provided adequate support for a 3-factor model. Additional estimates of concurrent validity documented the ADDI-27 scales' convergent and discriminant validity. We also identified three construct relevant correlates for each scale score. Overall, the ADDI-27 appears to be a content valid, reliable, and multidimensional measure of the tripartite model of affect. Concerns regarding the nature and structure of depression and anxiety have received extensive attention in the extant literature (Watson proposed the tripartite model of affect to address some of the concerns regarding the high overlap between anxiety and depression in self-report and clinical data. In particular, the domains of the tripartite model are characterized by symptoms of internalizing disorders: positive affect, negative affect, and anxious-arousal (i.e., physiological hyperarousal). Clinically, low positive affect responses (i.e., the absence of positive affect symptoms such as felt happy, felt optimistic, and felt good) are indicative of depression, and high-level anxious arousal responses (e.g., felt dizzy, hands were shaky, and trouble swallowing) are indicative of anxiety. High-level negative affect responses (e.g., worry, fear, and irritability) account for most of the shared (nonspecific) or overlapping symptoms of anxiety and depression. In terms of measurement, self-report instruments composed of positive affect and anxious arousal components are expected to have low to moderate negative correlations (i.e., rs typically range from À.35 to À.50; Cohen, 1988) among the derived scale scores (Keogh & Reidy, 2000). Furthermore, scores on self-report instruments composed of predominantly negative affect components are expected to be associated substantially (rs 5 .45 to .75) with scores on instruments designed to assess a range of mixed depression and anxiety responses, as
Journal of clinical psychology, 2018
The present study developed normative data for the expanded version of the Inventory of Depression and Anxiety Symptoms (IDAS-II). The IDAS-II is a self-report measure containing 18 factor-analytically derived scales, each assessing a specific symptom of internalizing disorders, including depression, anxiety disorders, OCD, bipolar disorder, and PTSD. These normative data were used to examine group differences in internalizing symptoms across demographic characteristics. A total of 1,836 Mechanical Turk users (47.6% male; mean age = 35.6) completed the IDAS-II; the sample was weighted to be representative of the U.S. population on gender, age, and race/ethnicity. Percentiles were derived for each of the IDAS-II scales. Age was the demographic characteristic most consistently associated with lower internalizing symptoms. The present study provides information on the distribution of specific internalizing symptoms in a large national sample, as well as on how these symptoms are relate...
Clinical Utility of the Inventory of Depression and Anxiety Symptoms (IDAS)
Assessment, 2018
Depressive and anxiety disorders are severe and disabling conditions that result in substantial cost and global societal burden. Accurate and efficient identification is thus vital to proper diagnosis and treatment of these disorders. The Inventory of Depression and Anxiety Symptoms (IDAS) is a reliable and well-validated measure that provides dimensional assessment of both mood and anxiety disorder symptoms. The current study examined the clinical utility of the IDAS by establishing diagnostic cutoff scores and severity ranges using a large mixed sample ( N = 5,750). Results indicated that the IDAS scales are good to excellent predictors of their associated Structured Clinical Interview for DSM-IV diagnoses. These findings were replicated using Diagnostic and Statistical Manual of Mental Disorders-Fifth edition (DSM-5) criteria assessed via the Mini-International Neuropsychiatric Interview. We provide three cutoff scores for each scale that can be used differentially depending on t...
Journal of Clinical Psychology, 2011
The authors conducted three studies to construct and examine the psychometric properties of a 27-item version of the Mood and Anxiety Symptom Questionnaire-90 (MASQ-90; Watson & Clark, 1991a). The Anxiety Depression Distress Inventory-27 (ADDI-27) contains three empirically derived scales: Positive Affect, Somatic Anxiety, and General Distress, which are relevant dimensions of the tripartite model of affect. Each scale is composed of nine items, and the estimate of scale reliability for each scale score was Z.80 across the three studies. Results of exploratory and confirmatory factor analyses provided adequate support for a 3-factor model. Additional estimates of concurrent validity documented the ADDI-27 scales' convergent and discriminant validity. We also identified three construct relevant correlates for each scale score. Overall, the ADDI-27 appears to be a content valid, reliable, and multidimensional measure of the tripartite model of affect.